Michael Leahy
Royal Perth Hospital(AU)Texas Health Dallas(US)Southwestern Medical Center(US)William C. Tallent Outpatient Clinic(US)Institute for Exercise and Environmental Medicine(US)Southwestern Medical CenterThe University of Texas Southwestern Medical Center(US)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Gastrointestinal Tumor Research and Treatment, Gastric Cancer Management and Outcomes, Gastrointestinal disorders and treatments, Vascular Tumors and Angiosarcomas
Most-Cited Works
- → Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial(2012)1,392 cited
- → Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986(2011)767 cited
- → Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial(2012)577 cited
- → Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial(2017)505 cited
- → Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial(2014)381 cited